Integra's (IART) Q4 Earnings Miss Estimates, Margins Down [Yahoo! Finance]
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: Yahoo! Finance
The metric missed the Zacks Consensus Estimate by 1.1%. The adjustment excludes the impact of certain non-recurring charges like amortization expenses, the Boston recall and EU Medical Device Regulation charges. GAAP EPS in the fourth quarter was 25 cents, plunging 60.3% from 63 cents in the year-ago quarter. For the full year, adjusted EPS was $3.10 compared with the year-ago period's figure of $3.36, down 7.7%. Revenue Discussion Total revenues in the reported quarter dropped 0.3% year over year to $397.04 million. The metric missed the Zacks Consensus Estimate by 0.4%. Organically, revenues fell 1.2% year over year. Revenues increased 3.6% on an organic basis excluding Boston. Total revenues in 2023 were $1.54 billion, down 1% from the year-ago period's figure. Segmental Details Coming to product categories, revenues in the Codman Specialty Surgical (CSS) segment rose 2.7% year over year on a reported basis to $271.6 million (organically, up 2.3%). This improvement
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific MeetingGlobeNewswire
- Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024GlobeNewswire
- Here's Why Investors Should Retain Integra (IART) Stock Now [Yahoo! Finance]Yahoo! Finance
IART
Earnings
- 2/28/24 - Miss
IART
Sec Filings
- 4/4/24 - Form ARS
- 4/4/24 - Form DEF
- 3/25/24 - Form PRE
- IART's page on the SEC website